Moreover, Kotler et al. (34) showed that the loss of the anti-proliferative function of WT P53 largely correlates with the occurrence of cancer-associated TP53 mutations, and that selective GOF properties may further favour specific mutants P53 in vivo. This evidence concerns the gene TP53 and cancer.